Ibuprofen topical - Crescita Therapeutics

Drug Profile

Ibuprofen topical - Crescita Therapeutics

Alternative Names: Ibufoam; Topical ibuprofen foam - Crescita Therapeutics

Latest Information Update: 11 May 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nuvo Research
  • Developer Crescita Therapeutics
  • Class Antirheumatics; Nonsteroidal anti-inflammatories; Phenylpropionates; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase I Acute pain

Most Recent Events

  • 11 May 2016 Chemical structure information added
  • 09 May 2016 Ibuprofen topical - Crescita Therapeutics is available for licensing as of 20 Aug 2015. http://www.crescitatherapeutics.com/
  • 09 May 2016 Phase-I clinical trials in Acute pain in Canada (Topical) prior to May 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top